Indications

For postmenopausal patients with early breast cancer adjuvant treatment, such patients estrogen or progesterone receptor positive or unknown receptor status . Already received adjuvant tamoxifen therapy for 5 years of adjuvant therapy, postmenopausal women with early breast cancer patients , such patients estrogen or progesterone receptor positive or unknown receptor status . Treatment of postmenopausal estrogen receptor-positive and progesterone receptor positive or unknown receptor status in patients with advanced breast cancer , these patients should be natural or artificial menopause induced menopause .